Gelonghui, March 19 | Spai Health (00314.HK) announced that for the year ended December 31, 2023, the company's revenue was 4.71 billion yuan, up 14.4% year on year; adjusted net loss was 150 million yuan, compared with a loss of 259 million yuan for the same period last year. The gross margin increased slightly from about 8.2% in 2022 to about 8.8% in 2023, mainly reflected in a sharp increase in the gross margin of the doctor research assistance service business and the relative stability of the gross margin of the health insurance service business.
思派健康(00314.HK)年度收入47.1亿元 同比增长14.4%
Sipai Health (00314.HK)'s annual revenue of 4.71 billion yuan increased 14.4% year-on-year
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.